Prime Medicine (PRME) Operating Expenses (2021 - 2026)

Prime Medicine's Operating Expenses history runs 6 years deep, the most recent figure standing at $51.5 million for Q1 2026.

• Quarterly Operating Expenses fell 4.34% year-over-year to $51.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210.6 million (changed 0.13% YoY) and the FY2025 annual result came in at $213.0 million, up 3.67% from the prior year.
• Operating Expenses was $51.5 million for Q1 2026 at Prime Medicine, up from $49.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $68.0 million in Q4 2023 and bottomed at $19.9 million in Q1 2022.
• A 5-year average of $46.5 million and a median of $49.4 million in 2025 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 203.59% in 2022, while the deepest fall reached 35.6% in 2022.
• Prime Medicine's Operating Expenses stood at $38.7 million in 2022, then jumped by 75.89% to $68.0 million in 2023, then plunged by 31.8% to $46.4 million in 2024, then climbed by 6.55% to $49.4 million in 2025, then increased by 4.17% to $51.5 million in 2026.
• Business Quant data shows PRME's Operating Expenses at $51.5 million in Q1 2026, $49.4 million in Q4 2025, and $55.2 million in Q3 2025.